XML 89 R67.htm IDEA: XBRL DOCUMENT
v3.25.2

SHARE CAPITAL (Narrative) (Details 1) | 1 Months Ended | 12 Months Ended
--- | --- | ---
Feb. 29, 2024 $ / shares | Mar. 31, 2025 CAD ($) Share $ / shares | Mar. 31, 2024 CAD ($) Share $ / shares
Consultants, employees and directors [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Number of stock options granted | Share |  | 2,000,000 | 1,250,000
Grant date fair value of stock options granted | $ |  | $ 1,802,247 | $ 1,545,175
Description of vesting |  | 621,250 at the date of issuance; 661,250 after 12 months from the date of issuance; 621,250 after 24 months from the date of issuance; and 96,250 after 36 months from the date of issuance. | 416,667 at the date of issuance; 350,000 after 6 months from the date of issuance; 416,667 after 12 months from the date of issuance; and 66,667 after 24 months from the date of issuance.
Consultants, employees and directors [Member] | Minimum [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Exercise price | $ / shares |  | $ 1.42 | $ 1.75
Consultants, employees and directors [Member] | Maximum [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Exercise price | $ / shares |  | $ 1.52 | $ 2.24
Triera Biosciences Ltd [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Number of stock options granted | Share |  | 5,000 | 195,000
Triera Biosciences Ltd [Member] | Consultants [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Number of stock options granted | Share |  | 5,000 |
Exercise price | $ / shares |  | $ 1 |
Description of vesting |  | The vesting period for the Triera stock options issued was as follows: 1,667 on June 1, 2024; 1,667 on June 1, 2025; and 1,666 on June 1, 2026. |
Triera Biosciences Ltd [Member] | Directors and Officers [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Number of stock options granted | Share |  |  | 195,000
Exercise price | $ / shares | $ 1 |  | $ 5
Description of vesting |  |  | The vesting period for the Triera stock options issued was as follows: 65,000 at the date of issuance; 65,000 after 6 months from the date of issuance; and 65,000 after 12 months from the date of issuance. In February 2024, the Company repriced the Triera stock options, reducing the exercise price from $5.00 per share to $1.00 per share.

X
- Definition The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Types of share-based payment arrangements [domain]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfClassesOfShareCapitalLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The exercise price of share options granted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ExercisePriceShareOptionsGranted2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of share options granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_ii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition Grant date fair value of stock options granted. + References No definition available. + Details
Name: | ztek_GrantDateFairValueOfStockOptionsGranted
Namespace Prefix: | ztek_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=ztek_ConsultantsEmployeesAndDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ztek_TrieraBiosciencesLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=ztek_ConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=ztek_DirectorsAndOfficersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |